Morganton, NC, United States of America

Jonathan E Sterling

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Exela Pharma Sciences, LLC. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan E Sterling. Retrieved from https://idiyas.com/inventor/jonathan-e-sterling-2tcffpzr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jonathan E Sterling

Introduction

Jonathan E Sterling is an accomplished inventor based in Morganton, NC (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, Sterling's work has the potential to impact patient care and treatment options.

Latest Patents

Sterling's latest patents focus on Ganciclovir compositions and related methods. These patents disclose Ganciclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage. Additionally, the patents provide methods of manufacture and administration of such compositions, showcasing Sterling's commitment to improving drug delivery systems.

Career Highlights

Sterling is currently associated with Exela Pharma Sciences, LLC, where he continues to innovate in the pharmaceutical sector. His work emphasizes the importance of developing stable and effective drug formulations that can enhance patient outcomes.

Collaborations

Throughout his career, Sterling has collaborated with notable professionals in the field, including Sreerama Murthy Mallipeddi and Phanesh B Koneru. These collaborations have further enriched his research and development efforts.

Conclusion

Jonathan E Sterling's contributions to pharmaceutical innovations, particularly in Ganciclovir formulations, highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also aims to improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…